Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT02775318
Eligibility Criteria:
Inclusion Criteria:
* Any patient with post aneurysm clipping having symptomatic vasospasm i:e new onset of focal neurological impairment such as hemiparesis, aphasia, apraxia, hemianopia, or neglect or decrease of at least 2 points on the Glasgow Coma Scale (GCS) and duration of symptoms lasting for at least 1 hour.
* Transcranial doppler confirmation of vasospasm by measuring cerebral blood flow velocity in MCA and LINDEGAARD ratio.
* Cerebral angiographic confirmation of the presence of vasospasm by Digital subtraction angiography
Exclusion Criteria:
* New onset of focal neurological deficit or deterioration in the level of consciousness due to other causes like re-bleeding, hydrocephalus, cerebral edema, electrolyte disorder, infection and seizure.
* Patients having an infarct on cerebral tomography.
* Patients with clipping of more than one aneurysm.
* Patients with bilateral neurological deficits.
* History of allergy to local anaesthetic agents.
* Refusal of consent.
* Deranged coagulation profile.
* Patients with pre-existing pupillary changes where assessment of effectiveness of Stellate ganglion block will be difficult.
* History of allergy to contrast media.
* Derangement of renal parameters
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02775318
Study Brief:
Protocol Section:
NCT02775318